Rejoni
Rejoni46About
What does Rejoni do?
Rejoni, Inc. is a privately held, clinical-stage company focused on developing innovative biomaterial therapies to improve uterine health. Their lead product candidate is Juveena Hy.
What is Rejoni's revenue?
StartupHub estimates Rejoni's annual revenue at $1.9M (range $1.1M to $6.2M, 68% confidence), based on comparable companies in the sector.
What is Rejoni's valuation?
StartupHub estimates Rejoni's effective valuation at $96.0M (range $62.5M to $150.0M, 23% confidence), based on comparable companies in the sector.
How much funding has Rejoni raised?
Rejoni has raised a total of $25M in funding. The most recent round on record is Funding Round.
Where is Rejoni headquartered?
Rejoni is headquartered in Bedford, Massachusetts, USA.
When was Rejoni founded?
Rejoni was founded in 2018.
What industry does Rejoni operate in?
Rejoni operates in Biotechnology, Healthcare, Medical Devices, Biotech, MedTech, HealthTech.
How many employees does Rejoni have?
Rejoni has approximately 19 people on record.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.